Pfizer will spend $43 billion to buy Seagen and deepen its reach into treating cancer. The pharmaceutical giant said Monday that it will pay $229 in cash for each Seagen share.
A drug used to treat asthma and other breathing problems is in short supply. Hospitals and pharmacies in the Miami Valley are noticing the shortage and now have to cut back on giving it out. Pharmacies and hospitals have been dealing with an albuterol shortage for months now, after the company that makes it filed for bankruptcy and shut down production.
The Food and Drug Administration will make a decision on whether to fully approve Eisai and Biogen’s Alzheimer’s treatment Leqembi by July 6, the companies announced Monday.
Last week, Walgreens said it will not distribute abortion pills in states where Republican officials have threatened legal action. Now a blue state says it will cut ties with the pharmacy giant because of the move.
An unprofitable biotech that pioneered a relatively new kind of cancer therapy has caught the attention of the world's largest drugmakers on the hunt for the next big opportunity in one of the industry's most lucrative markets.